Fact CheckerSign in

NCT07572773Recruiting

CHAMP Lung Cancer Screening Program

CHAMP: Community Health Assessment and Monitoring in the Pharmacy. Assessing the Impact of a Community Pharmacist Lung Cancer Screening (LCS) Program

Source: ClinicalTrials.gov · Last updated 16 Jun 2026

Brief summary (registry, in English)

The U.S. Preventive Services Task Force recommends annual lung cancer screening (LCS) with low-dose CT for adults aged 50-80 with a ≥20 pack-year smoking history who currently smoke or quit within the past 15 years. Despite insurance coverage, only 17% of eligible Iowans were screened in 2024. Barriers include the complexity of screening and competing demands in primary care. To address these challenges, investigators propose a two-part intervention: a blood-based screening test to simplify LCS and a community pharmacist-led referral program integrated into routine pharmacy care. Eligible patients will be identified at Greenwood Pharmacy in Waterloo, Iowa. Interested individuals will be consented by a pharmacist and engaged in shared decision-making about LCS. Participants may decline screening, complete the DELFI Diagnostics FirstLook lung cancer screening blood test, or pursue CT screening through their primary care physician. Those choosing the blood test will be referred to Cedar Valley Family Medicine. Patients with a positive result will complete a standard shared decision-making visit with their PCP and, if appropriate, undergo confirmatory CT imaging. Patients with a negative result will enter a screening cohort and be re-screened annually for an additional year.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
300 (estimated)
First submitted
23 Apr 2026
Start date
12 Jun 2026
Primary completion date
Jun 2028
Lead sponsor
Jill Kolesar
Diseases
Lung cancer
NCT number
NCT07572773

What you commit to

  • Study type: Interventional
  • Planned participants: 300
  • From 12 Jun 2026 to the primary completion date, Jun 2028
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • self-report of lung cancer screening in the last 12 months
  • psychiatric illness/social situations that would limit compliance with study requirements

Who the study is looking for

  • aged 50-77
  • smoking pack-year history of ≥ 20 years
  • current smoker or quit smoking 15 or less years ago
  • ability to understand and willingness to sign a written informed consent document

Age in the registry: 50 years to 77 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Iowa
Coordinator of this site? Confirm its status
Iowa CityUnited StatesRecruiting
Cedar Valley Primary Care & Walk-In Clinic
Coordinator of this site? Confirm its status
WaterlooUnited StatesRecruiting
Greenwood Pharmacy and Compounding Center
Coordinator of this site? Confirm its status
WaterlooUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.